INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

INTEL CORP ⋅ 10-Q ⋅ 7/24 Philip Morris International Inc. ⋅ 10-Q ⋅ 7/24 TEXAS INSTRUMENTS INC ⋅ 10-Q ⋅ 7/24 AMERICAN EXPRESS CO ⋅ 10-Q ⋅ 7/24 NEXTERA ENERGY INC ⋅ 10-Q ⋅ 7/24 CME GROUP INC. ⋅ 10-Q ⋅ 7/24 KINDER MORGAN, INC. ⋅ 10-Q ⋅ 7/24 TE Connectivity plc ⋅ 10-Q ⋅ 7/24 LAS VEGAS SANDS CORP ⋅ 10-Q ⋅ 7/24 HALLIBURTON CO ⋅ 10-Q ⋅ 7/24

Viatris Inc

Pharmaceutical Preparations | SIC: 2834
Phone: (724) 514-1465

CIK: 0001792044
EIN: 834364296
State Location: PA
State of Inc.: DE

Nasdaq:VTRS

Form: FWP

Filing Date: 12 Jun 2026
Report Date:
Accepted: 12 Jun 2026 02:10 p.m.
Accession Number: 0001140361-26-025065

Act: 34
File Number: 333-287087
Film Number: 261086750

Documents

Primary Document: FWP

Accepted: 12 Jun 2026 02:10 p.m.

0001140361-26-025065-index-headers.html

Last Modified: 12 Jun 2026 02:10 p.m.

0001140361-26-025065-index.html

Last Modified: 12 Jun 2026 02:10 p.m.

0001140361-26-025065.txt

Last Modified: 12 Jun 2026 02:10 p.m.